Review



human cardiac microvasculature endothelial cells  (PromoCell)


Bioz Verified Symbol PromoCell is a verified supplier
Bioz Manufacturer Symbol PromoCell manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 91
      Buy from Supplier

    Structured Review

    PromoCell human cardiac microvasculature endothelial cells
    Expression of antithrombin gene ( SERPINC1 ) in human <t>endothelial</t> cells and changes by incubation with Dexamethasone. (A) Expression of SERPINC1 in human cardiac <t>microvasculature</t> endothelial cells (hCMEC), human coronary artery endothelial cells (hCAEC), human aorta endothelial cells (hAEC) and HepG2 human hepatoma cells. Data are expressed as mean ± SE, n = 5. ∗∗∗ p < 0.05 vs. control the other two cell types. Statistical analysis was performed by one way ANOVA followed by Dunnett’s Multiple Comparison Test (GraphPad Prism 4 software). (B) Time Course (1–24 h) of SERPINC1 expression in hCAEC, hAEC, and hCMEC incubated with Dexamethasone 500 nM. Data are expressed as % of the control (mean ± SE, n = 4–5) ∗ p < 0.05 vs. control. Statistical analysis was performed by paired Student‘s t -test vs. control (GraphPad Prism 4 software).
    Human Cardiac Microvasculature Endothelial Cells, supplied by PromoCell, used in various techniques. Bioz Stars score: 91/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cardiac+microvasculature+endothelial+cells/pmc06167415-124-12-19?v=PromoCell
    Average 91 stars, based on 7 article reviews
    human cardiac microvasculature endothelial cells - by Bioz Stars, 2026-08
    91/100 stars

    Images

    1) Product Images from "Dexamethasone Preconditioning in Cardiac Procedures Reduces Decreased Antithrombin Activity and Is Associated to Beneficial Outcomes: Role of Endothelium"

    Article Title: Dexamethasone Preconditioning in Cardiac Procedures Reduces Decreased Antithrombin Activity and Is Associated to Beneficial Outcomes: Role of Endothelium

    Journal: Frontiers in Pharmacology

    doi: 10.3389/fphar.2018.01014

    Expression of antithrombin gene ( SERPINC1 ) in human endothelial cells and changes by incubation with Dexamethasone. (A) Expression of SERPINC1 in human cardiac microvasculature endothelial cells (hCMEC), human coronary artery endothelial cells (hCAEC), human aorta endothelial cells (hAEC) and HepG2 human hepatoma cells. Data are expressed as mean ± SE, n = 5. ∗∗∗ p < 0.05 vs. control the other two cell types. Statistical analysis was performed by one way ANOVA followed by Dunnett’s Multiple Comparison Test (GraphPad Prism 4 software). (B) Time Course (1–24 h) of SERPINC1 expression in hCAEC, hAEC, and hCMEC incubated with Dexamethasone 500 nM. Data are expressed as % of the control (mean ± SE, n = 4–5) ∗ p < 0.05 vs. control. Statistical analysis was performed by paired Student‘s t -test vs. control (GraphPad Prism 4 software).
    Figure Legend Snippet: Expression of antithrombin gene ( SERPINC1 ) in human endothelial cells and changes by incubation with Dexamethasone. (A) Expression of SERPINC1 in human cardiac microvasculature endothelial cells (hCMEC), human coronary artery endothelial cells (hCAEC), human aorta endothelial cells (hAEC) and HepG2 human hepatoma cells. Data are expressed as mean ± SE, n = 5. ∗∗∗ p < 0.05 vs. control the other two cell types. Statistical analysis was performed by one way ANOVA followed by Dunnett’s Multiple Comparison Test (GraphPad Prism 4 software). (B) Time Course (1–24 h) of SERPINC1 expression in hCAEC, hAEC, and hCMEC incubated with Dexamethasone 500 nM. Data are expressed as % of the control (mean ± SE, n = 4–5) ∗ p < 0.05 vs. control. Statistical analysis was performed by paired Student‘s t -test vs. control (GraphPad Prism 4 software).

    Techniques Used: Expressing, Incubation, Control, Comparison, Software



    Similar Products

    human cardiac microvasculature endothelial cells  (PromoCell)
    91
    PromoCell human cardiac microvasculature endothelial cells
    Expression of antithrombin gene ( SERPINC1 ) in human <t>endothelial</t> cells and changes by incubation with Dexamethasone. (A) Expression of SERPINC1 in human cardiac <t>microvasculature</t> endothelial cells (hCMEC), human coronary artery endothelial cells (hCAEC), human aorta endothelial cells (hAEC) and HepG2 human hepatoma cells. Data are expressed as mean ± SE, n = 5. ∗∗∗ p < 0.05 vs. control the other two cell types. Statistical analysis was performed by one way ANOVA followed by Dunnett’s Multiple Comparison Test (GraphPad Prism 4 software). (B) Time Course (1–24 h) of SERPINC1 expression in hCAEC, hAEC, and hCMEC incubated with Dexamethasone 500 nM. Data are expressed as % of the control (mean ± SE, n = 4–5) ∗ p < 0.05 vs. control. Statistical analysis was performed by paired Student‘s t -test vs. control (GraphPad Prism 4 software).
    Human Cardiac Microvasculature Endothelial Cells, supplied by PromoCell, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cardiac+microvasculature+endothelial+cells/pmc06167415-124-12-19?v=PromoCell
    Average 91 stars, based on 1 article reviews
    human cardiac microvasculature endothelial cells - by Bioz Stars, 2026-08
    91/100 stars
    		  Buy from Supplier

    Image Search Results


    Expression of antithrombin gene ( SERPINC1 ) in human endothelial cells and changes by incubation with Dexamethasone. (A) Expression of SERPINC1 in human cardiac microvasculature endothelial cells (hCMEC), human coronary artery endothelial cells (hCAEC), human aorta endothelial cells (hAEC) and HepG2 human hepatoma cells. Data are expressed as mean ± SE, n = 5. ∗∗∗ p < 0.05 vs. control the other two cell types. Statistical analysis was performed by one way ANOVA followed by Dunnett’s Multiple Comparison Test (GraphPad Prism 4 software). (B) Time Course (1–24 h) of SERPINC1 expression in hCAEC, hAEC, and hCMEC incubated with Dexamethasone 500 nM. Data are expressed as % of the control (mean ± SE, n = 4–5) ∗ p < 0.05 vs. control. Statistical analysis was performed by paired Student‘s t -test vs. control (GraphPad Prism 4 software).

    Journal: Frontiers in Pharmacology

    Article Title: Dexamethasone Preconditioning in Cardiac Procedures Reduces Decreased Antithrombin Activity and Is Associated to Beneficial Outcomes: Role of Endothelium

    doi: 10.3389/fphar.2018.01014

    Figure Lengend Snippet: Expression of antithrombin gene ( SERPINC1 ) in human endothelial cells and changes by incubation with Dexamethasone. (A) Expression of SERPINC1 in human cardiac microvasculature endothelial cells (hCMEC), human coronary artery endothelial cells (hCAEC), human aorta endothelial cells (hAEC) and HepG2 human hepatoma cells. Data are expressed as mean ± SE, n = 5. ∗∗∗ p < 0.05 vs. control the other two cell types. Statistical analysis was performed by one way ANOVA followed by Dunnett’s Multiple Comparison Test (GraphPad Prism 4 software). (B) Time Course (1–24 h) of SERPINC1 expression in hCAEC, hAEC, and hCMEC incubated with Dexamethasone 500 nM. Data are expressed as % of the control (mean ± SE, n = 4–5) ∗ p < 0.05 vs. control. Statistical analysis was performed by paired Student‘s t -test vs. control (GraphPad Prism 4 software).

    Article Snippet: Human aortic endothelial cells (hAEC), human coronary artery endothelial cells (hCAEC) and human cardiac microvasculature endothelial cells (hCMEC) from Promocell (Heidelberg, Germany) were seeded (50000 cells/plate) and grown until 80% confluence.in endothelial basal medium (EBM, Promocell) supplemented with fetal calf serum (FCS; 50 mL/mL), human basic fibroblast growth factor (hbFGF; 10 ng/mL), human vascular endothelial growth factor (hVEGF; 0.5 ng/mL), human epidermal growth factor (hEGF; 5 ng/mL), human recombinant insulin-like growth factor-1 (R3IGF-1; 20 ng/mL), ascorbic acid (1 mg/mL) and hydrocortisone (0.5 mg/mL), (all of them from Promocell; Heidelberg, Germany), 0.015 mg/mL amphotericin B (Biowhittaker; Lonza Basel, Switzerland) and 30 mg/mL gentamicin (Genta-Gobens; Laboratorios Normon SA, Tres Cantos, Madrid, Spain).

    Techniques: Expressing, Incubation, Control, Comparison, Software